A general method for greatly improving the affinity of antibodies by using combinatorial libraries - Wikidata - wikimedia - TriplyDB

A general method for greatly improving the affinity of antibodies by using combinatorial libraries

A general method for greatly improving the affinity of antibodies by using combinatorial libraries

http://www.wikidata.org/entity/Q33216580

about

Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone Applications of Yeast Surface Display for Protein Engineering Affinity maturation of antibodies assisted by in silico modeling.Data-Driven Antibody Engineering Using Genedata Biologics™.Ribosome display for improved biotherapeutic molecules.Optimizing the affinity and specificity of proteins with molecular display.An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10 Yeast surface display for protein engineering and characterization A decade of yeast surface display technology: where are we now?Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies Predicting protein evolution in vitro by phage escape technology.OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system.Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens.Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display.Identification of human single-chain antibodies with broad reactivity for noroviruses.Tailored amino acid diversity for the evolution of antibody affinity The influence of antibody fragment format on phage display based affinity maturation of IgG.Development trends for generation of single-chain antibody fragments.A sequence-specific threading tetra-intercalator with an extremely slow dissociation rate constant High-resolution sequence-function mapping of full-length proteins.Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen.Establishment of cell surface engineering and its development.Development of a biotinylated broad-specificity single-chain variable fragment antibody and a sensitive immunoassay for detection of organophosphorus pesticides.Protease substrate profiling using bacterial display of self-blocking affinity proteins and flow-cytometric sorting.Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values.Tuning the specificity of a Two-in-One Fab against three angiogenic antigens by fully utilizing the information of deep mutational scanning.Antibody engineering toward high-sensitivity high-throughput immunosensing of small molecules.Engineering the variable region of therapeutic IgG antibodies.Molecular engineering of antibodies for therapeutic and diagnostic purposes.Antibody-antigen pair probed by combinatorial approach and rational design: bringing together structural insights, directed evolution, and novel functionality.Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases.Methods for the directed evolution of proteins.Arming Technology in Yeast-Novel Strategy for Whole-cell Biocatalyst and Protein Engineering.Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge.Production of biologically active scFv and VHH antibody fragments in Bifidobacterium longum.Biosensor detection systems: engineering stable, high-affinity bioreceptors by yeast surface display.

P2860

Q24312937-CE8D7EF0-0020-4384-BEAB-0573FFBF6BBF Q26823830-CA367DEE-A269-42F4-B8EC-CD3FE880189B Q30482656-603CA471-4FD2-4A2B-80E0-FD864996DFC9 Q31170218-44DD226C-E633-4E45-B40C-7680C08B5294 Q33232465-62C4887C-5B51-4326-98CE-BE9BE0DF5ED0 Q33252425-B2FCF9E9-0087-4E87-BA91-891303F2DA6D Q33272711-438E8FD1-B190-49ED-9564-EFD891B02AF8 Q33299124-56933397-2023-4123-ABF7-AE847C5D6E10 Q33323464-EFFC2E1A-FCA1-4C12-ACD9-7EEFDC860D9B Q33328393-3F3653BF-888C-4FFF-B0C7-2139677A79B7 Q33401273-77744B22-7E44-40E3-87D4-E4600A5BC402 Q33694202-76236621-4C8C-4FC6-86B7-70C94B45DB67 Q34179215-2900EBBD-9537-46FA-834F-F6E46F32E291 Q34191098-798E2838-0441-453B-858D-9F87A65A6491 Q34244499-4A1162E1-379F-473F-BEC8-0CDDB9EBFE6E Q34313167-2DCC076A-A775-4648-A806-EBD646A27DCC Q34394742-5D373A65-4953-4D86-BACD-BA7D40C3B933 Q35050036-8AC09399-F3A4-4166-B54B-FA0466A6F1C3 Q35216785-508549F1-9F57-417A-B22D-8EAC5DD329EB Q35532827-43F99EBC-1DCF-4BD7-939C-F071F1A27E75 Q35581370-E10BEAA8-3972-4F07-BD74-49568398CEF3 Q35654123-79920832-7DF7-43A9-A0C1-A7BF5B0684C9 Q35818864-81189EB0-9A66-4F49-AA59-6B48E275D702 Q35888532-DA079425-D417-4A84-9729-4CFBC486C579 Q36053204-B2337AAF-1943-42DD-AE1D-39169562BBF3 Q36076426-73EF9D40-A956-4C95-AA0E-231588E7C24E Q36174822-1F29C9CF-3BCB-4AA3-BF26-ED03DCB6A4E5 Q36363440-7D78EECC-3856-4ECE-812F-A75DB58BAA26 Q36393842-D4DFF253-B2CA-452C-9089-30F80CCC006B Q37820247-2A869DE8-746D-4AD1-A43E-930290660B59 Q37853324-2943559C-8451-4199-91E7-3D87F7E9B9E7 Q38017581-0A9F4610-48F4-4482-98A2-F813F4546BC0 Q38030235-E2BEF348-A4BB-40C0-98B4-B31D744800B1 Q38382090-F2D2A653-8F23-43BE-B406-E39B8B0494F9 Q38521229-E5EB95D8-ECEF-4272-896D-4A76A203DB69 Q39871671-D0E140DD-4E01-4E88-AC66-16A86DF6F2AA Q40822573-9B39BC63-A040-4BAE-A351-6C40E3F38A0B Q41434430-60A18965-7BCB-4680-996D-FDFA7EAD9204 Q41726225-4A610741-4E79-4318-ADD7-BF2D06D3637B Q42019724-38C1AF1D-0B3A-44DA-A422-141DDF6F9E34

P2860

A general method for greatly improving the affinity of antibodies by using combinatorial libraries

http://www.wikidata.org/entity/Q33216580

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

A general method for greatly i ...... using combinatorial libraries

@ast

A general method for greatly i ...... using combinatorial libraries

@en

type

label

A general method for greatly i ...... using combinatorial libraries

@ast

A general method for greatly i ...... using combinatorial libraries

@en

prefLabel

A general method for greatly i ...... using combinatorial libraries

@ast

A general method for greatly i ...... using combinatorial libraries

@en

P1433

Q33216580-313BCB3A-0E46-465A-A57D-4E3BF03C987C

P1476

Q33216580-EEC3E36D-C049-46EC-90E5-4532CAAB7DF4

P2093

Q33216580-11D54D6E-0D27-421A-95B3-ABF46E1768EB

Q33216580-3C3A43DB-923B-4967-8C3D-7D9D7343DC33

Q33216580-59BB54ED-36BE-48EA-9266-333A014570D6

Q33216580-735D8511-326F-4E8F-8F8C-26977A5CCD80

Q33216580-783CAE4B-717F-403B-8CCD-B119E5C9860A

Q33216580-96481283-5F59-4B44-91B3-CB47686E2A25

Q33216580-9A5EE9B2-9BD9-408B-9B5B-AD0A6E5A008D

Q33216580-D20843E8-AED6-4CF2-9318-7ECDEEEE2237

Q33216580-E5D73CEF-1FE7-4718-AB6D-2174E68ABB39

P2860

Q33216580-01716A55-5670-4884-ACA8-F0BEFDFD3839

Q33216580-0D21DAB9-E83D-4800-B22C-004FC6F8C718

Q33216580-0DB7BCDE-950F-4426-96EB-8C20270F3087

Q33216580-1A07144A-4273-4897-8D43-6299A3ADB5B7

Q33216580-2E015BCD-ED6C-4243-8837-50820C53D658

Q33216580-2E6B8FEA-A8EF-49C0-9648-35BB042AA1AB

Q33216580-3A6C7D19-C71B-41C3-B30B-A0D7A9044D50

Q33216580-48DB3B93-C495-436A-B5C9-9451B7E05618

Q33216580-4E5EEC01-7352-41B3-AB9B-3CC5D1CCD497

Q33216580-4F6F7236-8F79-41D5-A24D-909E92EAA986

P304

Q33216580-29CA0C61-281E-4934-BD8A-89F6A1F5CFF9

P31

Q33216580-2681ADC4-E836-4A08-8D5E-A2576416D0FA

P356

Q33216580-5C3D8D0D-A306-483A-9E02-2731455A385F

P407

Q33216580-60E1455D-4FFB-405E-BDE6-1FC40DA4CB30

P433

Q33216580-3010373E-C626-41C1-9595-4C3580500D7F

P478

Q33216580-E09BF13C-D639-45A5-8FBA-898166314C82

P577

Q33216580-6BDD5C63-AA9F-4F32-8673-46F6D7B3B69E

P5875

Q33216580-F7AC2AB0-90CA-4D72-9452-75D93864E12B

P698

Q33216580-B89D0781-074E-42B2-A817-8C6D0111F973

P921

Q33216580-11EC83B2-4770-4B63-8664-6EB792A72256

P932

Q33216580-6524E930-FBC7-43B0-BAC7-657D5D04F77B

P356

PNAS.0503543102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A general method for greatly i ...... using combinatorial libraries

@en

P2093

Arvind Rajpal

http://www.w3.org/2001/XMLSchema#string

Guido Cappuccilli

http://www.w3.org/2001/XMLSchema#string

Helena Yee

http://www.w3.org/2001/XMLSchema#string

Lauric Haber

http://www.w3.org/2001/XMLSchema#string

Nurten Beyaz

http://www.w3.org/2001/XMLSchema#string

Ramesh R Bhatt

http://www.w3.org/2001/XMLSchema#string

Richard A Lerner

http://www.w3.org/2001/XMLSchema#string

Roberto Crea

http://www.w3.org/2001/XMLSchema#string

Toshihiko Takeuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Codon usage tabulated from international DNA sequence databases: status for the year 2000

Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen

Selection of phage antibodies by binding affinity. Mimicking affinity maturation

Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis

Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.

Improving antibody affinity by mimicking somatic hypermutation in vitro.

Tech.Sight. Phage display. Affinity selection from biological libraries.

In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin.

Complementary combining site contact residue mutations of the anti-digoxin Fab 26-10 permit high affinity wild-type binding.

Targeting random mutations to hotspots in antibody variable domains for affinity improvement.

P304

8466-8471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0503543102

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7802259

http://www.w3.org/2001/XMLSchema#string

P698

15939870

http://www.w3.org/2001/XMLSchema#string

P921

P932

1143585

http://www.w3.org/2001/XMLSchema#string